Earlier this year, two leaders at the National Institutes of Health said there is growing concern from scientists and laypeople that the system for ensuring the reproducibility of biomedical research “is failing and is in need of restructuring.”
The average price of computed tomography systems went up 15% in the past month as more hospitals purchased high-end scanners, including two new premium models that have been on the market for less than a year, according to the Modern Healthcare/ECRI Institute Technology Price Index.
Drug manufacturer AbbVie, which recently walked away from a merger with Irish drugmaker Shire, reported third-quarter earnings of $506 million, down 47% compared with the same period last year. It did, however, manage to beat analyst expectations for adjusted earnings at 89 cents per share.
The new online eBook from Carestream Health, From Trust to Use and Beyond, presents some of the explorations and successes along the road to clinical information access. The ebook was created to stimulate discussion on some of healthcare information systems' most critical issues. As information...
The Food and Drug Administration authorized use of two new diagnostic tests for Ebola that can produce results in two hours, compared with what can usually take four hours.
Stephen Ubl became president and CEO in 2005 of the Advanced Medical Technology Association, a 270-member group representing manufacturers of medical devices, diagnostic products and medical information systems. Modern Healthcare reporter Sabriya Rice recently spoke with Ubl about the potential...
Stephen Ubl, president and CEO of the Advanced Medical Technology Association, discusses the potential impact of new payment models, as well as regulatory and tax issues, on the $110 billion device industry. He spoke with Modern Healthcare reporter Sabriya Rice.
A Johnson & Johnson unit's design of a metal-on-metal version of its Pinnacle hip implants isn't defective, a Dallas jury concluded, ruling against a woman who said the devices poisoned her in the first case of its kind to go to trial.
Intuitive Surgical, a surgical robotics company, reported a 21% decrease in earnings in the third quarter, despite broader adoption of its flagship da Vinci system worldwide.
A study is questioning the use of robots in gynecological surgery after they produced inferior outcomes and had higher costs compared with laparoscopy, the major alternative.
The average cost of anesthesia systems went up 28% in July because of an increase in the number of hospitals buying higher-acuity systems, according to the Modern Healthcare/ECRI Institute Technology Price Index.
Using surgical robots for procedures on the ovaries, fallopian tubes or ovarian cysts does not produce better outcomes and also has higher costs, a study published this month argues.